Home / Biotechnology / Global Hig

Global High Throughput Process Development Market By Product (Consumables and Reagents and Instruments), By Process (Upstream and Downstream), By Molecule Type (Monoclonal Antibodies, Vaccines, Recombinant Insulin, Human Growth Hormones and Others) - Growth, Future Prospects & Competitive Analysis, 2017 - 2025

For the purpose of this study, the various products studied includes consumables and reagents, and instruments. The process are classified as upstream and downstream.

Based on molecule type, this market is further segmented as monoclonal antibodies, vaccines, recombinant insulin, human growth hormones and others. Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global high throughput process development market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The regions are also further sub-segmented on the basis of major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global high throughput process development market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global high throughput process development market. The major players in high throughput process development market are Agilent Technologies, Inc., Axxam S.P.A., Aurora Biomed, Bio-Rad Laboratories, Inc., Danaher Corporation, Hamilton Company, Merck Millipore Corporation, Perkin Elmer, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc.

High Throughput Process Development Market

Based on product types, the global high throughput process development market is categorized into

  • Consumables and Reagents
  • Instruments

 

High Throughput Process Development Market


The high throughput process development market is driven by factors such as rising prevalence of chronic diseases, aging population and burgeoning requirement for launch of novel drugs to counteract the multiple drug resistance bacterial infection. In addition, increasing number of diagnostic centers and growing physician awareness regarding disease etiology will propel the market penetration for high throughput screening. In 2016, instruments segment held the largest market share chiefly due to factors such as technological advancement in automation techniques and huge application in biopharmaceuticals, contract research organizations, and research institutes etc.

Consumables and reagents will be the fastest growing segment throughout the forecast period 2017-2025 majorly due to factors such as rising prevalence of chronic diseases, steadily increasing diagnostic centers and public private partnership to combat life threatening diseases by setting research and development centers. The major players in high throughput screening market are Agilent Technologies, Inc., Axxam S.P.A., Aurora Biomed, Bio-Rad Laboratories, Inc., Danaher Corporation, Hamilton Company, Merck Millipore Corporation, Perkin Elmer, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc.

For the purpose of this study, the global high throughput process development market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

High Throughput Process Development Market 

North America was observed to be the largest market for high throughput process development in the base year 2016. The dominance of North America is mainly attributed to the presence of major giants in biotechnology and pharmaceutical industries focusing on novel drug discovery of biological drug candidates, and existence of advanced healthcare and research facilities. The market growth in Europe is mainly attributed to the increasing number of patients suffering with chronic diseases. This factor boosts the demand for lowering the manufacturing cost of biological drugs and reducing the product development timelines. Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth in Asia Pacific are presence of large patient pool which can be enrolled to study the safety and efficacy studies for biological drug candidates during clinical trials and enhanced research and development spending by the governmental organizations. Moreover, factors such as developing healthcare infrastructure, and public private partnership between major biopharmaceutical players and academic research institutes are going to fuel the rapid growth of high throughput process development market in Latin America, and Middle East and Africa in the near future.   

Choose License Type
Published Date:  Oct 2017
Category:  Biotechnology
Report ID:   58745
Report Format:   PDF
Pages:   120
Rating:    4.2 (55)
Connect With Us
+1-408-641-3282
24/7 Research Support